Get Email Alerts
James P. Kiley, Ph.D.
To arrange an interview, please contact the NHLBI Communications Office at 301-496-4236 or nhlbi_news@nhlbi.nih.gov.
Biography
James P. Kiley, Ph.D., joined the National Heart, Lung, and Blood Institute (NHLBI) in 1984 as Health Scientist Administrator in the Institute's Division of Lung Diseases. From 1989-1994, Dr. Kiley served as Chief of the Division's Airways Diseases Branch. From 1995-2000 he served as Director of the National Center on Sleep Disorders Research, which is part of NHLBI. He was named Director of the Division of Lung Diseases in 2000. Dr. Kiley's primary research interests include obstructive and interstitial lung diseases and sleep.
Dr. Kiley received his M.S. and Ph.D. degrees from Kansas State University, Manhattan, KS in 1978 and 1982, respectively. He received his B.A. in 1974 from St. Anselm's College, Manchester, NH.
Dr. Kiley is the author or coauthor of more than 85 scientific publications and abstracts. He has served as a reviewer for the Journal of Applied Physiology, Chest, Respiratory Physiology, the Journal of the U.S. Public Health Service, and the Journal of Clinical Investigations.
Areas of expertise: obstructive and interstitial lung diseases, sleep.
Dr. Kiley In the News
December 26, 2012
Benefits of higher oxygen, breathing device persist after infancy
By the time they reached toddlerhood, very preterm infants originally treated with higher oxygen levels continued to show benefits when compared to a group treated with lower oxygen levels, according to a follow-up study by a research network of the National Institutes of Health that confirms earlier network findings, Moreover, infants treated with a respiratory therapy commonly prescribed for adults with obstructive sleep apnea fared as well as those who received the traditional therapy for infant respiratory difficulties, the new study found.
December 3, 2012
: NIH News in Health
Technique may improve COPD detection
An experimental method can distinguish between different types of chronic obstructive pulmonary disease (COPD) and track disease progression. The method may eventually lead to more accurate diagnoses and more effective treatments for COPD, a lung disease that makes it hard to breathe.
View all Dr. Kiley in the news articles
Twitter
Facebook
YouTube